Search for: "Price v. GlaxoSmithKline LLC" Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Skinny Label Safe Harbor
6 May 2022, 8:10 am by Dennis Crouch
Cir. 2021), en banc denied at GlaxoSmithKline LLC v. [read post]
Patently-O - https://patentlyo.com
conjoint analysis has to isolate challenged representations
29 Mar 2024, 10:04 am by Rebecca Tushnet
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, --- F.Supp.3d ----, 2024 WL 348821, No: 4:20-cv-09077-JSW (N.D. [read post]
43(B)log - http://tushnet.blogspot.com/
Inducing Infringement by Making a Product Available
6 Oct 2020, 8:19 am by Dennis Crouch
GlaxoSmithKline LLC v. [read post]
Patently-O - http://patentlyo.com/patent
His Name was RICO, He Wore a Diamond: Lawsuits Allege that Coupons and Savings Programs for Brand-Name Drugs Violate RICO, Antitrust Law
12 Mar 2012, 5:41 pm by FDABlog HPM
GlaxoSmithKline LLC, No. 12-cv-01191 (E.D.Pa., Mar. 7, 2012) (Complaint) New England Carpenters Health and Welfare Fund v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Director-Shareholder Suit Trips on Limitations Period
2 Jan 2015, 10:15 am by John Jascob
Court of International Trade, wrote for a unanimous Eleventh Circuit panel (100079 Canada, Inc. v. [read post]
Jim Hamilton's World of Securities Regulation - http://jimhamiltonblog.blogspot.com/
Pharma & Biotech Global Week in Review 31 March 2010 from IP Think Tank
1 Apr 2010, 3:04 am
– TRIPS and price controls on patented pharmaceutical products (patentidbits) Assessing pharma patent strength (JIPLP) Canada: Health Canada releases final guidances on biosimilars (Pharmacapsules) US: District Court S D New York: ‘Isolated DNA’ patents fail to claim patentable subject matter: Association for Molecular Pathology and ACLU v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
District Court Permits Damage Expert to Testify Regarding Comparable Licenses That Contained “Built-In Apportionment” of Royalties
17 Oct 2022, 11:27 am by Stan Gibson
Glaxosmithkline LLC, 981 F.3d 1030, 1040 (Fed. [read post]
Patent Lawyer Blog - http://patentlaw.jmbm.com/
No State-Law Market For "Fraud On The Market"
25 Jan 2010, 5:00 am by Beck, et al.
S & M NuTec LLC, 245 F.R.D. 429, 438 (C.D. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Skinny Label Doesn’t Prevent Infringement Liability
2 Nov 2020, 1:41 pm by Courtenay C. Brinckerhoff
The Federal Circuit decision in GlaxoSmithKline LLC v. [read post]
PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents
IP Think Tank Global Week in Review - 18 April 2008
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
IP Think Tank Global Week in Review - 29 February 2008
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog